Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Nuvalent, Inc.

NUVLNASDAQ
Healthcare
Biotechnology
$104.06
$0.00(0.00%)
U.S. Market is Open • 15:55

Nuvalent, Inc. (NUVL) Stock Overview

Explore Nuvalent, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7.3B
P/E Ratio-18.91
EPS (TTM)$-5.33
ROE-0.39%
Fundamental Analysis

AI Price Forecasts

1 Month$90.27
3 Months$79.35
1 Year Target$122.76

NUVL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nuvalent, Inc. (NUVL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $122.76.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -18.91 and a market capitalization of 7.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.42%
5-Day Change
-1.49%
1-Month Change
-5.13%
3-Month Change
-6.95%
6-Month Change
37.22%
Year-to-Date (YTD) Change
-0.34%
1-Year Change
21.98%
3-Year Change
220.47%
5-Year Change
436.00%
All-Time (Max) Change
436.00%

Contact Information

857 357 7000
One Broadway, Cambridge, MA, 02142

Company Facts

1,620 Employees
IPO DateJul 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions